Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	40.27	12.47	25.29	30.61	31.83	218.31
Short-Term Investments	58.81	121.14	207.64	171.12	259.41	-
Cash & Short-Term Investments	99.07	133.61	232.94	201.73	291.23	218.31
Cash Growth	-50.93%	-42.64%	15.47%	-30.73%	33.40%	1056.36%
Prepaid Expenses	3.33	2.28	2.65	2.65	3.88	2.5
Total Current Assets	102.4	135.9	235.59	204.38	295.12	220.81
Property, Plant & Equipment	34.7	35.47	37.74	6.7	5.64	2.48
Other Long-Term Assets	4.15	4.15	4.34	9.42	4.35	0.3
Total Assets	141.26	175.52	277.67	220.5	305.1	223.59
Accounts Payable	5.83	7.73	4.58	6.78	7.84	3.92
Accrued Expenses	10.61	14.44	14.82	12.57	9.53	7.04
Current Portion of Leases	2.65	2.7	1.48	1.83	1.74	-
Other Current Liabilities	0.7	0.77	0.95	0.52	0.09	0.42
Total Current Liabilities	19.79	25.64	21.83	21.7	19.2	11.38
Long-Term Leases	15.27	15.33	15.41	-	-	-
Other Long-Term Liabilities	3.03	3.09	3.34	3.36	-	0.03
Total Liabilities	38.08	44.06	40.58	25.06	19.2	11.41
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	718.81	714.98	693.25	531.68	505.72	319.61
Retained Earnings	-615.65	-583.56	-456.39	-334.56	-219.12	-107.43
Comprehensive Income & Other	0.01	0.04	0.22	-1.69	-0.71	-
Total Common Equity	103.18	131.46	237.09	195.44	285.9	212.18
Shareholders' Equity	103.18	131.46	237.09	195.44	285.9	212.18
Total Liabilities & Equity	141.26	175.52	277.67	220.5	305.1	223.59
Total Debt	17.92	18.03	16.89	1.83	1.74	-
Net Cash (Debt)	81.15	115.59	216.05	199.9	289.49	218.31
Net Cash Growth	-55.96%	-46.50%	8.08%	-30.95%	32.61%	1072.38%
Net Cash Per Share	1.07	1.52	3.58	4.22	6.29	17.49
Filing Date Shares Outstanding	56.46	55.15	54.89	47.71	47.02	45.37
Total Common Shares Outstanding	56.45	55.15	54.89	47.7	46.99	42.49
Working Capital	82.62	110.25	213.76	182.68	275.91	209.43
Book Value Per Share	1.83	2.38	4.32	4.10	6.08	4.99
Tangible Book Value	103.18	131.46	237.09	195.44	285.9	212.18
Tangible Book Value Per Share	1.83	2.38	4.32	4.10	6.08	4.99
Machinery	-	10.33	8.97	5.72	4.38	2.72
Construction In Progress	-	-	0.34	1.64	0.67	-
Leasehold Improvements	-	1.7	1.58	0.88	0.88	0.45

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q